MMR

AbbVie Stock Inching Toward Highs Amid Drug Sale Talks

Citigroup raised its price target to $125 from $105

Deputy Editor
Mar 16, 2021 at 10:19 AM
facebook X logo linkedin


AbbVie Inc (NYSE:ABBV) is in the spotlight this morning, after news that the pharmaceutical company is in talks to sell a $5 billion portfolio of women's drugs. According to Reuters, the company acquired these drugs through its $63 billion purchase of Allergan this past year. Furthermore, Citigroup today raised its price target on the equity to $125 from $105. At last check, ABBV was up 0.5% to trade at $110.76.

On the charts, ABBV has been creeping up toward its recent Jan. 13 nearly three-year high of $113.41. A double layer of support looks to have formed at both the $102 level and 80-day moving average. Year-over-year, the equity is up 49%. 

Analysts are mostly bullish on AbbVie stock, with 12 of the 16 analysts in coverage at a "buy" or better rating. Plus, the 12-month consensus price target of $122.63 comes into today with a 10.8% premium to current levels. 

Sentiment is similar in the options pits. ABBV's 50-day call/put volume ratio of 3.69 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands higher than 91% of readings from the past year. This means long calls have been picked up at a much faster-than-usual rate over the last 10 weeks. 

Now might not be a bad time to weigh in on these options either. The stock's Schaeffer's Volatility Index (SVI) of 25% stands higher than just 9% of all other readings in its annual range, implying that options players are pricing in relatively low volatility expectations at the moment. 

 

AI has exploded ever since ChatGPT set the world on fire near the end of 2022.

Numerous companies with connections to artificial intelligence have seen their stocks soar.

That includes Nvidia, the poster boy of AI.

Its stock has skyrocketed 716% since ChatGPT’s debut. But here’s the thing …

While everyone’s still counting their money from this first AI boom … Nvidia and countless others have moved on to the next stage.

That includes Big Tech, which is currently making a series of peculiar investments in a few strange companies. This has nothing to do with tech. At least on the surface …

Yet, these strange investments could be the early ripples of a massive wave …Without them, ChatGPT could stop operating … Amazon, Google, Microsoft and more could see profits drop drastically.

In fact, Elon Musk says these investments are critical when it comes to solving the number one problem facing AI.

Now, Silicon Valley legend Michael Robinson has identified two companies that could play a significant role in the solution.

Their stocks just may be the key to AI 2.0.

Find out more about these two companies today.
 (ad)